Nitrates Updated 1997
DOI: 10.1007/978-1-4613-1135-5_3
|View full text |Cite
|
Sign up to set email alerts
|

Mechanisms of Nitrate Tolerance

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
12
0

Year Published

1999
1999
2013
2013

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 12 publications
(12 citation statements)
references
References 51 publications
0
12
0
Order By: Relevance
“…However, tachyphylaxis to nitroglycerin may develop rather quickly and up to 20% of those with HF may develop resistance to even high doses. [605][606][607] Sodium nitroprusside is a balanced preload-reducing venodilator and afterload-reducing arteriodilator that also dilates the pulmonary vasculature. Data demonstrating efficacy are limited, and invasive hemodynamic blood pressure monitoring is typically required.…”
Section: Vasodilatorsmentioning
confidence: 99%
“…However, tachyphylaxis to nitroglycerin may develop rather quickly and up to 20% of those with HF may develop resistance to even high doses. [605][606][607] Sodium nitroprusside is a balanced preload-reducing venodilator and afterload-reducing arteriodilator that also dilates the pulmonary vasculature. Data demonstrating efficacy are limited, and invasive hemodynamic blood pressure monitoring is typically required.…”
Section: Vasodilatorsmentioning
confidence: 99%
“…However, tachyphylaxis to nitroglycerin may develop within 24 hours, and up to 20% of those with HF may develop resistance to even high doses. [766][767][768] Sodium nitroprusside is a balanced preload-reducing venodilator and afterload-reducing arteriodilator that also dilates the pulmonary vasculature. 769 Data demonstrating efficacy are limited, and invasive hemodynamic blood pressure monitoring (such as an arterial line) is typically required; in such cases, blood pressure and volume status should be monitored frequently.…”
Section: Diuretics In Hospitalized Patientsmentioning
confidence: 99%
“…One of the major drawbacks of NO donating agent therapy in cardiovascular diseases is the rapid development of pharmacological tolerance. It develops shortly after the beginning of treatment and occurs both in vitro and in vivo conditions [32,33] . Both human and experimental studies showed that prolonged exposure to high levels of nitroglycerin and other organic nitroesters induce tolerance against the cardiovascular effects of the drugs [17][18][19][20] .…”
Section: Discussionmentioning
confidence: 99%
“…The mechanisms of nitrate tolerance are complex and multi-factorial, including processes such as decreased tissue sulphydryl availability, reduced bioactivation of the parent drug, physiological compensation and tissue oxidative stress [32,33,35] . Some investigators suggested that tolerance may arise from one or more steps involving the biotransformation process of organic nitrates prior to the formation of NO [21,22] .…”
Section: Discussionmentioning
confidence: 99%